HAYWARD, Calif.--(BUSINESS WIRE)--Oct. 23, 2018--
Pulse Biosciences, Inc. (NASDAQ: PLSE), a novel medical therapy company
bringing to market its proprietary Nano-Pulse Stimulation™ platform,
today announced that the Company will report third quarter 2018
operational highlights and financial results on Tuesday, October 30,
2018. Pulse Biosciences management will host a conference call and
webcast at 4:30 p.m. Eastern Time (ET) / 1:30 p.m. Pacific Time (PT).
Analysts and investors can participate in the conference call by dialing
(844) 494-0190 (domestic) and (508) 637-5580 (international) using the
conference ID# 2098843. The webcast of the conference call can be
accessed live on the Investor Relations section of the Pulse Biosciences
website at www.pulsebiosciences.com.
About Pulse Biosciences
Pulse Biosciences is a novel medical therapy company bringing to market
its proprietary Nano-Pulse Stimulation™ (NPS™) platform. NPS is a novel,
precise, non-thermal, treatment technology delivering nanosecond
duration energy pulses that impact cells in treated tissue while sparing
surrounding acellular tissue. NPS’s unique mechanism of action disrupts
the functions of internal cell structures while maintaining the outer
cell membrane initiating a cascade of events within the cell that
results in regulated cell death. In pre-clinical studies, NPS has
demonstrated an ability to induce immunogenic cell death in cancer cell
lines. The novel characteristics of NPS’s unique mechanism of action has
the potential to significantly benefit patients for multiple medical
applications, including dermatology, the Company’s first planned
commercial application, with future potential in other disease states
where an enhanced immune response may be beneficial. More information is
available at www.pulsebiosciences.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181023006120/en/
Source: Pulse Biosciences, Inc.
Pulse Biosciences, Inc.
Vice President and Chief Financial Officer
Gitanjali Jain Ogawa, 646-378-2949
Nadine D. Tosk, 504-453-8344